Related Experiment Videos
Vasculitis and nephritis caused by pramipexole, a second generation dopamine agonist
Clinical and Experimental Rheumatology
|January 11, 2005
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Eczematous reactions in patients with plaque psoriasis receiving biological therapy: an observational study.
European review for medical and pharmacological sciences·2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).
The Journal of dermatological treatment·2024
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study.
Expert opinion on biological therapy·2023
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis.
Frontiers in immunology·2023
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Outcome and risk factors for progression in IgG4-related disease under watchful waiting.
Clinical and experimental rheumatology·2026
Safety and procedural success of minor salivary gland biopsy in Sjögren's disease: a retrospective analysis of 202 patients.
Clinical and experimental rheumatology·2026
AI-augmented rheumatologist? Reflections on AI-induced technostress, job insecurity and professional identity.
Clinical and experimental rheumatology·2026
The role of phospholipase D4 in inflammatory autoimmune diseases.
Clinical and experimental rheumatology·2026
Risk factors and long-term follow-up in acute Kawasaki disease patients with medium or large coronary artery aneurysms.
Clinical and experimental rheumatology·2026
DHHC21 is a STIM1 protein S-acyltransferase that modulates immune function in vivo.
Journal of cell science·2026
The hypusine circuit: eIF5A at the crossroads of polyamine metabolism, malignant progression, and therapeutic vulnerability.
Biochimica et biophysica acta. Reviews on cancer·2026